Insiders · Profile

Lee Gary K.

Chief Scientific Officer at Lyell Immunopharma. Filing since 11 Aug 2025. CIK 0001907345

Company
Date
Role
Action
Shares
Amount
Of holding
21 Aug 2026
Chief Scientific Officer
Sold at will
1,457
$22.64K
8.2%
10 Aug 2026
Chief Scientific Officer
Sold at will
131
$1.88K
0.7%
11 May 2026
Chief Scientific Officer
Sold at will
130
$2.46K
0.7%
11 Feb 2026
Chief Scientific Officer
Sold at will
1,671
$39.08K
9.0%
10 Feb 2026
Chief Scientific Officer
Sold at will
147
$3.40K
0.8%
10 Nov 2025
Chief Scientific Officer
Sold at will
138
$2.23K
0.9%
21 Aug 2025
Chief Scientific Officer
Sold at will
1,453
$15.32K
8.6%
12 Aug 2025
Chief Scientific Officer
Sold at will
136
$1.41K
1.5%
11 Aug 2025
Chief Scientific Officer
Sold at will
131
$1.38K
1.4%
9 decisions on file.